Sign in →

Test Code IMML52 hCG, Quant (Tumor Marker)

Clinical Information

This test is not useful as a cancer screening test. Serum markers are not specific for malignancy and values may vary by method. Values obtained with different assay methods cannot be used interchangeably. Normal serum levels of hCG do not always exclude tumor persistence since tumors may undergo transition to differentiated teratomas, which may not produce hCG. Transient elevations of serum hCG can occur following chemotherapy in patients with susceptible tumors, due to massive tumor cell lysis; these transient elevations should not be confused with tumor progression. For assays employing antibodies, the possibility exists for interference by human anti-animal antibodies (i.e., heterophile antibodies) in the patient sample. Patients who have been regularly exposed to animals or have received immunotherapy or diagnostic procedures utilizing immunoglobulins or immunoglobulin fragments may produce antibodies, (eg, HAMA), that interfere with immunoassays. This may falsely elevate or falsely decrease the results.

Synonym

  • HCGTM

Specimen Required

Preferred Container/Tube: Gold SST Top
Acceptable Container/Tube: Gold SST Top
Specimen Volume: 3 mL
Specimen Minimum Volume: 1 mL

Specimen Stability Information

Ambient: 8 hours
Refrigerated: 5 days

Rejected Due To

  • Gross hemolysis
  • Gross icterus
  • Quantity not sufficient
  • Quality not acceptable

Reference Values

<10.0 mIU/mL

Method Description

Two-site sandwich immunoassay chemiluminescent.

Performing Lab

Clinical Lab UH
Clinical Lab University East
Clinical Lab James
Clinical Lab West Campus

Day(s) Performed

Monday through Sunday

Report Available

Same day/1 day

Reporting Name

hCG, Quant (Tumor Marker)

CPT Code Information

84702

LOINC Code Information

19080-1